Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry

A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying. Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combinat...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmaceutics and biopharmaceutics Vol. 80; no. 3; pp. 649 - 656
Main Authors: Huyge, Katrien, Van Reeth, Kristien, De Beer, Thomas, Landman, Wil J.M., van Eck, Jo H.H., Remon, Jean Paul, Vervaet, Chris
Format: Journal Article
Language:English
Published: Amsterdam Elsevier B.V 01-04-2012
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying. Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combination with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as stabilizers. These powders were evaluated for vaccine stabilizing capacity during production and storage (at 6°C and 25°C), moisture content, hygroscopicity and dry powder dispersibility. A mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer combination which resulted in the desired powder properties (i.e. good vaccine stability during production and storage, low moisture content and hygroscopicity and good dry dispersibility). Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders compared to PVP-containing formulations. However, increasing the BSA concentration increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid mathematical model could be calculated for vaccine stability during production or storage, but the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6–2.0 log10 50% egg infectious dose (EID50) and storage at 6°C (max. 0.8 log10 EID50 after 6months) in combination with a low moisture content (1.1–1.4%), low hygroscopicity (1.9–2.1% water uptake at 60% relative humidity) and good dry dispersibility properties.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0939-6411
1873-3441
DOI:10.1016/j.ejpb.2011.11.018